Computer-Aided Detection Global Market Report 2025

The computer-aided detection market size has grown strongly in recent years. It will grow from $0.98 billion in 2024 to $1.08 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period is attributed to increasing cancer incidence rates, expanded use of medical imaging technologies, a growing shortage of radiologists, government-sponsored screening programs, and a heightened emphasis on early detection.

The computer-aided detection market size is expected to see strong growth in the next few years. It will grow to $1.55 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth anticipated in the forecast period is driven by an expanding geriatric population, increasing volumes of imaging data, the rise of telehealth and remote diagnostics, the growing importance of precision medicine, and advancements in healthcare infrastructure. Key trends during this time include the integration of deep learning, real-time decision support systems, cloud-based CAD platforms, developments in multimodal CAD systems, and the incorporation of natural language processing.

The increasing prevalence of breast cancer is expected to drive growth in the computer-aided detection (CAD) market going forward. Breast cancer is a malignant tumor that develops in breast cells, typically starting in the ducts or lobules, and can spread to nearby tissues or other parts of the body if not detected and treated early. Rising breast cancer rates are largely linked to lifestyle changes, such as increasing obesity, which raises estrogen levels that may promote cancer growth. CAD improves breast cancer diagnosis by analyzing medical images to detect potential abnormalities, allowing for earlier and more accurate identification. It assists radiologists in detecting tumors that might otherwise be missed, enhancing screening accuracy. For example, in October 2024, the American Cancer Society, a US-based cancer organization, reported approximately 310,720 new invasive breast cancer cases among US women, with diagnoses of ductal carcinoma in situ (DCIS) increasing to 56,500. Similarly, in October 2022, the American Cancer Society estimated 287,850 new invasive breast cancer cases and 51,400 DCIS cases diagnosed in US women. Thus, the growing prevalence of breast cancer is fueling the expansion of the computer-aided detection market.

Leading companies in the computer-aided detection market are concentrating on developing advanced technologies like artificial intelligence (AI)-powered computer-aided detection (CADe) software to improve diagnostic accuracy, streamline image analysis, and facilitate early disease detection. AI-powered CADe software utilizes artificial intelligence to examine medical images for signs of abnormalities, boosting diagnostic precision and supporting early identification of diseases such as cancer. For example, in March 2025, Align Technology, Inc., a Switzerland-based provider of digital orthodontics and restorative dentistry, introduced Align X-ray Insights for dental radiograph analysis. This AI-driven software enhances dental image analysis to provide more accurate diagnostics and improves workflow efficiency by delivering real-time insights within existing imaging systems. The solution is designed to help dental professionals across the EU and UK offer precise and timely patient care.

In June 2023, Olympus Corporation, a Japan-based provider of medical and surgical equipment and solutions, acquired Odin Vision for $75.31 million. This acquisition enhances Olympus’s presence in the digital health sector by incorporating Odin Vision’s advanced artificial intelligence (AI) capabilities into its endoscopy product lineup, improving the accuracy and efficiency of diagnostic procedures. The move highlights Olympus’s dedication to innovation and advancing healthcare through cutting-edge technology. Odin Vision, based in the UK, is a cloud-AI endoscopy company specializing in computer-aided detection and diagnostic (CAD) solutions.

Major players in the computer-aided detection market are Hitachi Ltd., International Business Machines Corporation (IBM), Fujifilm Holdings Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Hologic Inc., Canon Medical Systems Corporation, Agfa-Gevaert NV, Carestream Health Inc., ESAOTE S.p.A., Aidoc Medical Ltd., Median Technologies S.A., iCAD Inc., Riverain Technologies LLC, Nano-X Imaging Ltd., Zebra Medical Vision Ltd., CureMetrix Inc., EDDA Technology Inc., and THERAPIXEL S.A.S.

North America was the largest region in the computer-aided detection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in computer-aided detection report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the computer-aided detection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Computer-aided detection (CAD) is a medical imaging technology that utilizes algorithms and artificial intelligence (AI) to analyze scans and detect possible abnormalities like tumors or fractures. It acts as an assistive tool for radiologists, providing a second opinion to support early and accurate diagnosis. By enhancing detection accuracy and reducing missed cases, CAD improves overall diagnostic reliability.

The primary computer-aided detection products include mammography, ultrasound imaging, magnetic resonance imaging, tomosynthesis, computed tomography, and others. Mammography combines low-dose X-rays with CAD to detect early signs of breast cancer and other abnormalities with greater precision. CAD is applied across various conditions such as tuberculosis, breast cancer, lung cancer, colon cancer, prostate cancer, liver cancer, bone cancer, and neurological disorders, serving end users like hospitals, clinics, diagnostic centers, and more.

The computer-aided detection market research report is one of a series of new reports that provides computer-aided detection market statistics, including the computer-aided detection industry global market size, regional shares, competitors with the computer-aided detection market share, detailed computer-aided detection market segments, market trends, opportunities, and any further data you may need to thrive in the computer-aided detection industry. This computer-aided detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The computer-aided detection market consists of revenues earned by entities by providing services such as medical image analysis, diagnosis assistance, data management and reporting, and pre-screening support. The market value includes the value of related goods sold by the service provider or included within the service offering. The computer-aided detection market also includes sales of nuclear medicine imaging systems, endoscopy-based computer-aided detection systems, and dermoscopic imaging computer-aided detection systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.